HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection.
Nucleoside analogs (NAs) are used to treat numerous viral infections and cancer. They compete with endogenous nucleotides (dNTP/NTP) for incorporation into nascent DNA/RNA and inhibit replication by preventing subsequent primer extension. To date, an integrated mathematical model that could allow th...
Enregistré dans:
Auteurs principaux: | Max von Kleist, Philipp Metzner, Roland Marquet, Christof Schütte |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5aaee68234c7490a82b0e8db82cfe3e8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine
par: Olga Rechkoblit, et autres
Publié: (2018) -
Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase
par: Robert P. Hayes, et autres
Publié: (2021) -
Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle
par: Zhang C, et autres
Publié: (2020) -
Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers
par: Han Chen, et autres
Publié: (2021) -
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase
par: Salvatore Ferla, et autres
Publié: (2018)